pert_iname,LTKBID,PubChem_CID,Compound.Name,ApprovalYear,DILIConcern,Severity.Class,Label.Section,AdjudicatedDILI,vDILIConcern,Greene_Annotation,Sakatis_Annotation,Xu_Annotation,Zhu_Annotation,SMILES,URL..accessed.on.1.21.2016.,VER_DISP..1.LTKB.BD..2.others.,BROAD_ID,CPD_NAME,CPD_NAME_TYPE,CPD_SAMPLE_ID,DOS_LIBRARY,SOURCE_NAME,CHEMIST_NAME,VENDOR_CATALOG_ID,CPD_SMILES,USERCOMMENT,pert_id
albendazole,LT00499,2082,albendazole,1996,Most-DILI-Concern,7,Warnings and precautions,Yes,vMost-DILI-Concern,HH,.,Positive,Postive,CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3b7e8429-0b57-477f-ba44-51789a5d0da1,2,BRD-K79131256-001-03-9,albendazole,INN,SA58834,NA,MicroSource Discovery Systems Inc.,NA,1503903,CCCSc1ccc2[nH]c(NC(=O)OC)nc2c1,NA,BRD-K79131256
alfuzosin,LT01107,2092,alfuzosin,2003,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,.,.,.,.,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f075a897-7bef-4799-b7e2-7e051c461443,2,BRD-A09056319-003-03-6,alfuzosin,INN,SA83332,NA,Prestwick Chemical Inc.,NA,Prestw-322,COc1cc2nc(nc(N)c2cc1OC)N(C)CCCNC(=O)C1CCCO1,NA,BRD-A09056319
amantadine,LT00503,2130,amantadine,1968,Less-DILI-Concern,3,Warnings and precautions,.,Ambiguous DILI-concern,NE,.,Negative,.,C1C2CC3CC1CC(C2)(C3)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ce3e1ae0-17f4-4fa3-9d9c-4239c54ae6ea,1,BRD-K70330367-001-02-4,amantadine,INN,SA82056,NA,Biomol International Inc.,NA,AC-133,NC12CC3CC(CC(C3)C1)C2,NA,BRD-K70330367
amiloride,LT02070,16231,amiloride,1981,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,NE,.,Negative,Postive,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=135f9cb8-17b6-e99a-57c3-2d992eddb8ef,2,BRD-K97181089-001-02-7,amiloride,INN,SA82057,NA,Biomol International Inc.,NA,CA-200,NC(=N)NC(=O)c1nc(Cl)c(N)nc1N,NA,BRD-K97181089
amiodarone,LT00046,2157,amiodarone,1985,Most-DILI-Concern,8,Box warning,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=51be39a2-9134-402c-95ad-defe47406ff8,1,BRD-K17561142-003-19-2,amiodarone,INN,SA1855016,NA,Prestwick Chemical Inc.,NA,Prestw-409,CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1,NA,BRD-K17561142
amitriptyline,LT00047,2160,amitriptyline,1961,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,WE,Hepatotoxic,Negative,Postive,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=091b3ffc-ccef-47f9-b13a-ef2812e02630,2,BRD-K53737926-003-04-7,amitriptyline,INN,SA58178,NA,MicroSource Discovery Systems Inc.,NA,1500117,CN(C)CCC=C1c2ccccc2CCc2ccccc12,NA,BRD-K53737926
amlodipine,LT00175,2162,amlodipine,1992,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,.,non-hepatotixic,.,Postive,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bef1a169-9186-43e9-b673-64fdb658984f,2,BRD-A22032524-074-03-2,amlodipine,INN,SA792925,NA,Tocris Bioscience,NA,2571,CCOC(=O)C1=C(COCCN)NC(C)=C(C1c1ccccc1Cl)C(=O)OC,NA,BRD-A22032524
amoxapine,LT00256,2170,amoxapine,1980,Less-DILI-Concern,3,Adverse reactions,.,Ambiguous DILI-concern,WE,.,Negative,.,C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a16297df-3158-48db-85e5-5cd506885556,2,BRD-K02265150-001-04-2,amoxapine,INN,SA58947,NA,MicroSource Discovery Systems Inc.,NA,2300161,Clc1ccc2Oc3ccccc3N=C(N3CCNCC3)c2c1,NA,BRD-K02265150
benazepril,LT01116,5362124,benazepril,1991,Less-DILI-Concern,4,Adverse reactions,Yes,vLess-DILI-Concern,WE,.,Negative,.,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(C2=O)CC(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c51a3704-c5b3-471f-afcb-0602da0f3dce,2,BRD-K49807096-003-02-3,benazepril,INN,SA59554,NA,MicroSource Discovery Systems Inc.,NA,1505200,CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(O)=O)C1=O,NA,BRD-K49807096
betaxolol,LT01132,2369,betaxolol,1985,Less-DILI-Concern,3,Adverse reactions,.,Ambiguous DILI-concern,.,.,.,.,CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bf716efe-0a9f-43b1-9d8a-c69330b82e18,2,BRD-A02759312-003-11-2,betaxolol,INN,SA792210,NA,Tocris Bioscience,NA,906,CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1,NA,BRD-A02759312
biperiden,LT00817,2381,biperiden,1959,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,.,.,.,.,C1CCN(CC1)CCC(C2CC3CC2C=C3)(C4=CC=CC=C4)O,,1,BRD-A36471396-003-02-2,biperiden,INN,SA83388,NA,Prestwick Chemical Inc.,NA,Prestw-502,OC(CCN1CCCCC1)(C1C[C@H]2C[C@@H]1C=C2)c1ccccc1,NA,BRD-A36471396
bisacodyl,LT02190,2391,bisacodyl,.,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,.,.,.,.,CC(=O)OC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC(=O)C)C3=CC=CC=N3,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9448e8ba-b73a-4d2a-b58c-afdcd19f8e12,2,BRD-K39987650-001-04-3,bisacodyl,INN,SA58198,NA,MicroSource Discovery Systems Inc.,NA,1500147,CC(=O)Oc1ccc(cc1)C(c1ccc(OC(C)=O)cc1)c1ccccn1,NA,BRD-K39987650
bromocriptine,LT00279,31101,bromocriptine,1978,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,.,.,.,.,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=deeea4f0-389e-4b2f-b0a7-60a87feac62a,2,BRD-A80151636-066-02-2,bromocriptine,INN,SA59628,NA,MicroSource Discovery Systems Inc.,NA,1500151,CC(C)CC1N2C(=O)[C@](NC(=O)C3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(OC2(O)[C@@H]2CCCN2C1=O)C(C)C,NA,BRD-A80151636
bromocriptine,LT00279,31101,bromocriptine,1978,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,.,.,.,.,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=deeea4f0-389e-4b2f-b0a7-60a87feac62a,2,BRD-A60274948-066-02-9,bromocriptine,INN,SA83329,NA,Prestwick Chemical Inc.,NA,Prestw-121,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)C4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]2CCCN2C1=O)C(C)C,NA,BRD-A60274948
brompheniramine,LT02076,6834,brompheniramine,1957,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,.,.,Negative,.,CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=74b92bdf-5447-4932-a265-39891a4557a4,2,BRD-A68723818-050-04-4,brompheniramine,INN,SA58861,NA,MicroSource Discovery Systems Inc.,NA,1503985,CN(C)CCC(c1ccc(Br)cc1)c1ccccn1,NA,BRD-A68723818
bumetanide,LT01145,2471,bumetanide,1983,Less-DILI-Concern,3,Warnings and precautions,.,Ambiguous DILI-concern,HH,.,Positive,.,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=925b309a-8a0b-4bcd-bdf4-1ec42780ecc2,2,BRD-K38197229-001-06-7,bumetanide,INN,SA82195,NA,Biomol International Inc.,NA,EI-168,CCCCNc1cc(cc(c1Oc1ccccc1)S(N)(=O)=O)C(O)=O,NA,BRD-K38197229
bupropion,LT00058,444,bupropion,1985,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,WE,.,Negative,Postive,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5cb7fd36-ae36-409b-af79-9c432e1cf5d9,1,BRD-A05186015-003-04-0,bupropion,INN,SA58524,NA,MicroSource Discovery Systems Inc.,NA,1504174,CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,NA,BRD-A05186015
cabergoline,LT01152,54746,cabergoline,1996,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,.,.,.,.,CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)CC=C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=74b61e8a-7ae9-4996-85ec-df23c56de16f,2,BRD-K86882815-001-01-6,cabergoline,common,SA82670,NA,Biomol International Inc.,NA,AC-1359,CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(CC=C)C1,NA,BRD-K86882815
caffeine,LT01888,2519,caffeine,1999,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,NE,non-hepatotixic,Negative,.,CN1C=NC2=C1C(=O)N(C(=O)N2C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fbcd234e-57e1-4da2-a96c-e3f7b7cf6ec0,2,BRD-K02404261-001-02-7,caffeine,USP,SA37853,NA,AnalytiCon Discovery GmbH,NA,NP-004763,Cn1cnc2n(C)c(=O)n(C)c(=O)c12,NA,BRD-K02404261
calcitriol,LT00899,134070,calcitriol,1978,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,.,.,.,.,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@H](C[C@@H](C3=C)O)O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=167a669f-7b7e-46ea-9331-567bf19d8787,2,BRD-K27316855-001-02-6,calcitriol,INN,SA81905,NA,Biomol International Inc.,NA,DM200,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C1/C[C@@H](O)C[C@H](O)C1=C,NA,BRD-K27316855
carbamazepine,LT00060,2554,carbamazepine,1968,Most-DILI-Concern,7,Warnings and precautions,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7f9ed987-5e34-4536-a22f-4898c9797e61,1,BRD-K71799949-001-04-2,carbamazepine,INN,SA58205,NA,MicroSource Discovery Systems Inc.,NA,1500159,NC(=O)N1c2ccccc2C=Cc2ccccc12,NA,BRD-K71799949
carbinoxamine,LT00759,2564,carbinoxamine,1974,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,.,.,.,.,CN(C)CCOC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1edca669-8879-408a-b09c-259e363dd95c,1,BRD-A29426959-050-04-1,carbinoxamine,INN,SA58207,NA,MicroSource Discovery Systems Inc.,NA,1500161,CN(C)CCOC(c1ccc(Cl)cc1)c1ccccn1,NA,BRD-A29426959
carvedilol,LT00207,2585,carvedilol,1995,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,.,.,.,.,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2ba6d893-ae2a-4535-b904-667d206f93af,2,BRD-A10977446-001-04-8,carvedilol tartrate,primary-common,SA792982,NA,Tocris Bioscience,NA,2685,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,NA,BRD-A10977446
celecoxib,LT00252,2662,celecoxib,1998,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,.,.,Positive,Postive,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8d52185d-421f-4e34-8db7-f7676db2a226,2,BRD-K02637541-001-02-4,celecoxib,INN,SA59876,NA,MicroSource Discovery Systems Inc.,NA,1503678,Cc1ccc(cc1)-c1cc(nn1-c1ccc(cc1)S(N)(=O)=O)C(F)(F)F,NA,BRD-K02637541
cetirizine,LT01190,2678,cetirizine,1995,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,.,.,.,.,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dd9ae7a8-35dd-4c50-8be6-d06188f4c037,2,BRD-A42571354-300-01-3,cetirizine,INN,SA23196,NA,TimTec LLC,NA,ST024755,OC(=O)COCCN1CCN(CC1)C(c1ccccc1)c1ccc(Cl)cc1,NA,BRD-A42571354
chloroquine,LT01207,2719,chloroquine,1949,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,WE,non-hepatotixic,Negative,.,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=eb02c52d-907c-43fb-aa8f-2f378a9087e7,1,BRD-A91699651-316-04-2,chloroquine,INN,SA58221,NA,MicroSource Discovery Systems Inc.,NA,1500179,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,NA,BRD-A91699651
chlorpromazine,LT00068,2726,chlorpromazine,1957,Less-DILI-Concern,2,Adverse reactions,Yes,vLess-DILI-Concern,HH,Hepatotoxic,Positive,Postive,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b9d57be1-17cb-42ac-8334-ef3494be7f17,1,BRD-K89997465-001-02-0,chlorpromazine,INN,SA58226,NA,MicroSource Discovery Systems Inc.,NA,1500184,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc12,NA,BRD-K89997465
chlorthalidone,LT01213,2732,chlorthalidone,1960,Less-DILI-Concern,2,Adverse reactions,.,Ambiguous DILI-concern,.,.,.,.,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e2eb7dad-3ea3-439c-dcbb-d1d61aa49dfc,2,BRD-A26384407-001-04-6,chlorthalidone,INN,SA58229,NA,MicroSource Discovery Systems Inc.,NA,1500187,NS(=O)(=O)c1cc(ccc1Cl)C1(O)NC(=O)c2ccccc12,NA,BRD-A26384407
cilostazol,LT01025,2754,cilostazol,1999,Less-DILI-Concern,5,Adverse reactions,.,Ambiguous DILI-concern,.,non-hepatotixic,.,.,C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=66e0ed7b-e29a-45ee-82bb-3db6142c2697,2,BRD-K67017579-001-13-3,cilostazol,INN,SA792594,NA,Tocris Bioscience,NA,1692,O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1,NA,BRD-K67017579
cimetidine,LT01218,2756,cimetidine,1977,Less-DILI-Concern,2,Adverse reactions,Yes,vLess-DILI-Concern,WE,Hepatotoxic,Negative,.,CC1=C(N=CN1)CSCCNC(=NC)NC#N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c1694b2d-6fbb-b800-370b-0bf31220cb35,1,BRD-K34157611-001-03-8,cimetidine,INN,SA59269,NA,MicroSource Discovery Systems Inc.,NA,1500684,CN\C(NCCSCc1nc[nH]c1C)=N/C#N,NA,BRD-K34157611
clemastine,LT02222,26987,clemastine,1977,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,NE,non-hepatotixic,Negative,.,C[C@@](C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)OCC[C@H]3CCCN3C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b7e88fa7-fa92-48be-86ab-7e375d710251,1,BRD-K30240666-051-05-0,clemastine,INN,SA83250,NA,Prestwick Chemical Inc.,NA,Prestw-306,CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1,NA,BRD-K30240666
clomipramine,LT00185,2801,clomipramine,1989,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,.,Positive,.,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3823106e-6be3-4154-a607-caa3a69dc75c,2,BRD-K52989797-001-01-1,clomipramine,INN,SA82514,NA,Biomol International Inc.,NA,AC-572,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc12,NA,BRD-K52989797
clozapine,LT00287,2818,clozapine,1989,Most-DILI-Concern,5,Warnings and precautions,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,.,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8672ee49-ee2e-4239-98ce-7e23e1ab7b10,1,BRD-K37289225-001-07-5,clozapine,INN,SA82216,NA,Biomol International Inc.,NA,D107,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,NA,BRD-K37289225
danazol,LT00539,28417,danazol,1976,Most-DILI-Concern,8,Box warning,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,.,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC5=C(C[C@]34C)C=NO5,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=db372b81-28e6-44c7-a6c8-1c15362bec0d,1,BRD-K48970916-001-03-0,danazol,INN,SA82854,NA,Prestwick Chemical Inc.,NA,Prestw-105,C[C@]12CC[C@H]3[C@@H](CCC4=Cc5oncc5C[C@]34C)[C@@H]1CC[C@@]2(O)C#C,NA,BRD-K48970916
dantrolene,LT00080,2952,dantrolene,1974,Most-DILI-Concern,8,Box warning,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,.,C1C(=O)NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=57b4eec1-49e1-432c-95ae-0fe36e32d64b,1,BRD-K81272440-001-02-6,dantrolene,INN,SA82064,NA,Biomol International Inc.,NA,AC-100,[O-][N+](=O)c1ccc(cc1)-c1ccc(\C=N\N2CC(=O)NC2=O)o1,NA,BRD-K81272440
daunorubicin,LT00540,30323,daunorubicin,1979,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,.,.,.,.,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)C)O)N)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=64c62283-a6e8-48c7-8918-d6955bea5eb0,2,BRD-K43389675-003-02-7,daunorubicin,INN,SA83348,NA,Prestwick Chemical Inc.,NA,Prestw-487,COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(C)=O,NA,BRD-K43389675
dexamethasone,LT00082,5743,dexamethasone,1958,Less-DILI-Concern,3,Adverse reactions,.,Ambiguous DILI-concern,.,non-hepatotixic,Negative,.,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=95984c21-5734-4cba-a173-70eb88e3c8cf,1,BRD-K38775274-001-02-3,dexamethasone,INN,SA82229,NA,Biomol International Inc.,NA,EI-126,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,NA,BRD-K38775274
dexamethasone,LT00082,5743,dexamethasone,1958,Less-DILI-Concern,3,Adverse reactions,.,Ambiguous DILI-concern,.,non-hepatotixic,Negative,.,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=95984c21-5734-4cba-a173-70eb88e3c8cf,1,BRD-K47635719-001-03-9,dexamethasone acetate,primary-common,SA82861,NA,Prestwick Chemical Inc.,NA,Prestw-130,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(C)=O,NA,BRD-K47635719
dextromethorphan,LT02056,5360696,dextromethorphan,1982,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,NE,.,Negative,.,CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5daa0727-02ba-4f8e-86a9-2286716648bc,2,BRD-K33211335-337-03-7,dextromethorphan,INN,SA83256,NA,Prestwick Chemical Inc.,NA,Prestw-359,COc1ccc2C[C@H]3[C@H]4CCCC[C@@]4(CCN3C)c2c1,NA,BRD-K33211335
diazoxide,LT00865,3019,diazoxide,1973,Less-DILI-Concern,3,Warnings and precautions,.,Ambiguous DILI-concern,.,.,.,.,CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b16c7832-2fd9-49af-b923-1dc0d91fd6e2,2,BRD-K73109821-001-05-2,diazoxide,INN,SA82065,NA,Biomol International Inc.,NA,KC-115,CC1=Nc2ccc(Cl)cc2S(=O)(=O)N1,NA,BRD-K73109821
diclofenac,LT00084,3033,diclofenac,1988,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8e6e1aea-d1c9-f6bf-2a8c-0504437be95c,1,BRD-K08252256-236-04-9,diclofenac,INN,SA58265,NA,MicroSource Discovery Systems Inc.,NA,1500237,OC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl,NA,BRD-K08252256
diflunisal,LT00085,3059,diflunisal,1982,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,.,Positive,.,C1=CC(=C(C=C1C2=C(C=C(C=C2)F)F)C(=O)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7a78bb38-14d8-4a90-b883-482d4cebf716,2,BRD-K22031190-001-04-6,diflunisal,INN,SA58272,NA,MicroSource Discovery Systems Inc.,NA,1500245,OC(=O)c1cc(ccc1O)-c1ccc(F)cc1F,NA,BRD-K22031190
digoxin,LT00292,30322,digoxin,1975,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,NE,non-hepatotixic,Negative,.,C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=62795623-a2bc-4dd2-8989-3b9782bfd80e,1,BRD-K23478508-001-03-7,digoxin,INN,SA82874,NA,Prestwick Chemical Inc.,NA,Prestw-437,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]1[C@@H](O)C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3CC[C@@]4(C)[C@H](CC[C@@H]5[C@@H]4C[C@@H](O)[C@]4(C)[C@H](CC[C@]54O)C4=CC(=O)OC4)C3)O[C@@H]2C)O[C@@H]1C,NA,BRD-K23478508
dihydroergotamine,LT02218,10531,dihydroergotamine,1946,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,.,.,.,Negative,C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@@H]5C[C@H]6[C@@H](CC7=CNC8=CC=CC6=C78)N(C5)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fe826e6a-75c8-43ed-9c36-f8263ec35aff,1,BRD-A54845972-066-01-5,dihydro-ergotamine,to-be-curated,SA791991,NA,Tocris Bioscience,NA,475,CN1CC(CC2C1Cc1c[nH]c3cccc2c13)C(=O)NC1(C)OC2(O)C3CCCN3C(=O)C(Cc3ccccc3)N2C1=O,NA,BRD-A54845972
diltiazem,LT01292,39186,diltiazem,1982,Most-DILI-Concern,4,Warnings and precautions,Yes,vMost-DILI-Concern,.,non-hepatotixic,Negative,Postive,CC(=O)O[C@@H]1[C@@H](SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a662fc04-c296-4c24-8e36-ce7f9bcbd2ed,2,BRD-K81029756-001-02-8,L-cis-DILTIAZEM,to-be-curated,SA82080,NA,Biomol International Inc.,NA,CA-207,COc1ccc(cc1)[C@H]1Sc2ccccc2N(CCN(C)C)C(=O)[C@H]1OC(C)=O,NA,BRD-K81029756
diltiazem,LT01292,39186,diltiazem,1982,Most-DILI-Concern,4,Warnings and precautions,Yes,vMost-DILI-Concern,.,non-hepatotixic,Negative,Postive,CC(=O)O[C@@H]1[C@@H](SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a662fc04-c296-4c24-8e36-ce7f9bcbd2ed,2,BRD-K24023109-001-02-5,diltiazem,INN,SA82067,NA,Biomol International Inc.,NA,CA-205,COc1ccc(cc1)[C@@H]1Sc2ccccc2N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,NA,BRD-K24023109
diltiazem,LT01292,39186,diltiazem,1982,Most-DILI-Concern,4,Warnings and precautions,Yes,vMost-DILI-Concern,.,non-hepatotixic,Negative,Postive,CC(=O)O[C@@H]1[C@@H](SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a662fc04-c296-4c24-8e36-ce7f9bcbd2ed,2,BRD-A69636825-003-02-1,diltiazem,INN,SA58799,NA,MicroSource Discovery Systems Inc.,NA,2300214,COc1ccc(cc1)C1Sc2ccccc2N(CCN(C)C)C(=O)C1OC(C)=O,NA,BRD-A69636825
dipyridamole,LT00294,3108,dipyridamole,1961,Less-DILI-Concern,3,Warnings and precautions,.,Ambiguous DILI-concern,NE,.,Negative,.,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dcf785b2-e923-43bf-93bb-00a9501479f4,2,BRD-K86301799-001-14-0,dipyridamole,INN,SA792098,NA,Tocris Bioscience,NA,691,OCCN(CCO)c1nc(N2CCCCC2)c2nc(nc(N3CCCCC3)c2n1)N(CCO)CCO,NA,BRD-K86301799
disopyramide,LT01302,3114,disopyramide,1977,Less-DILI-Concern,2,Adverse reactions,Yes,vLess-DILI-Concern,HH,.,Positive,.,CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=11a68e26-d2e4-48f6-ba0f-9bdd5778f25a,2,BRD-A29734509-011-02-9,disopyramide,INN,SA58284,NA,MicroSource Discovery Systems Inc.,NA,1500261,CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C,NA,BRD-A29734509
dobutamine,LT01308,36811,dobutamine,1978,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,NE,.,Negative,.,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6b17b98b-e06d-42ed-925f-69aa2699dead,1,BRD-A78322124-003-09-0,dobutamine,INN,SA1855043,NA,Prestwick Chemical Inc.,NA,Prestw-352,CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,NA,BRD-A78322124
doxepin,LT01314,667477,doxepin,1969,Less-DILI-Concern,4,Adverse reactions,Yes,vLess-DILI-Concern,.,.,.,.,CN(C)CC/C=C/1\C2=CC=CC=C2COC3=CC=CC=C31,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f350afed-120b-422d-9e6e-3aaa0f72a5fb,2,BRD-K54462405-003-03-3,doxepin,INN,SA82890,NA,Prestwick Chemical Inc.,NA,Prestw-263,CN(C)CC\C=C1/c2ccccc2COc2ccccc12,NA,BRD-K54462405
doxylamine,LT00727,3162,doxylamine,1948,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,.,.,.,.,CC(C1=CC=CC=C1)(C2=CC=CC=N2)OCCN(C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bf64865f-4cf8-444a-9106-62abf2f22879,2,BRD-A44008656-036-04-3,doxylamine,INN,SA58289,NA,MicroSource Discovery Systems Inc.,NA,1500267,CN(C)CCOC(C)(c1ccccc1)c1ccccn1,NA,BRD-A44008656
enalapril,LT00296,5362032,enalapril,1985,Less-DILI-Concern,7,Adverse reactions,Yes,vLess-DILI-Concern,.,.,.,Postive,CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e31289f1-4b59-418a-a893-c748ce073f6c,1,BRD-K57545991-050-03-3,enalapril,INN,SA59358,NA,MicroSource Discovery Systems Inc.,NA,1501214,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O,NA,BRD-K57545991
eplerenone,LT01149,150310,eplerenone,2002,Less-DILI-Concern,4,Adverse reactions,.,Ambiguous DILI-concern,.,.,.,.,C[C@]12CCC(=O)C=C1C[C@H](C3[C@]24C(O4)C[C@]5([C@H]3CC[C@@]56CCC(=O)O6)C)C(=O)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6d988699-95c2-46b9-8266-23fe7016f33b,2,BRD-A39969961-001-01-3,eplerenone,to-be-curated,SA792841,NA,Tocris Bioscience,NA,2397,COC(=O)C1CC2=CC(=O)CCC2(C)C23OC2CC2(C)C(CCC22CCC(=O)O2)C13,NA,BRD-A39969961
estradiol,LT00016,5757,estradiol,1954,Less-DILI-Concern,2,Adverse reactions,Yes,vLess-DILI-Concern,WE,Hepatotoxic,Negative,.,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8ce4e37f-b55b-40cd-a194-ded0056ca594,1,BRD-K18910433-001-04-4,estradiol,INN,SA82244,NA,Biomol International Inc.,NA,BL-093,C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O,NA,BRD-K18910433
estradiol,LT00016,5757,estradiol,1954,Less-DILI-Concern,2,Adverse reactions,Yes,vLess-DILI-Concern,WE,Hepatotoxic,Negative,.,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8ce4e37f-b55b-40cd-a194-ded0056ca594,1,BRD-A23226398-001-02-7,estradiol,to-be-curated,SA59346,NA,MicroSource Discovery Systems Inc.,NA,1501184,CC(=O)OC1CCC2C3CCc4cc(O)ccc4C3CCC12C,NA,BRD-A23226398
estrone,LT02043,5870,estrone,1979,Less-DILI-Concern,2,Warnings and precautions,.,Ambiguous DILI-concern,HH,.,Positive,.,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=09ff0633-2992-4aba-96ed-45a69f3ee589,2,BRD-K81839095-001-02-0,estrone,INN,SA38535,NA,AnalytiCon Discovery GmbH,NA,NP-010065,C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CCC2=O,NA,BRD-K81839095
estropipate,LT00677,5284555,estropipate,1977,Less-DILI-Concern,2,Adverse reactions,.,Ambiguous DILI-concern,.,.,.,.,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)O.C1CNCCN1,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5ee9f406-8fdb-467f-9019-f9c11423bd91,2,BRD-K51095933-231-03-2,estropipate,USP,SA83602,NA,Prestwick Chemical Inc.,NA,Prestw-688,C[C@]12CC[C@H]3[C@@H](CCc4cc(OS(O)(=O)=O)ccc34)[C@@H]1CCC2=O,NA,BRD-K51095933
etodolac,LT00240,3308,etodolac,1991,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,.,.,.,Postive,CCC1=CC=CC2=C1NC3=C2CCOC3(CC)CC(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=86719bea-90f8-4696-ad0c-10a31967c850,1,BRD-A74667430-001-04-6,etodolac,INN,SA59309,NA,MicroSource Discovery Systems Inc.,NA,1501005,CCc1cccc2c3CCOC(CC)(CC(O)=O)c3[nH]c12,NA,BRD-A74667430
ezetimibe,LT01153,150311,ezetimibe,2002,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,.,.,.,Postive,C1=CC(=CC=C1[C@@H]2[C@H](C(=O)N2C3=CC=C(C=C3)F)CC[C@@H](C4=CC=C(C=C4)F)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a773b0b2-d31c-4ff4-b9e8-1eb2d3a4d62a,2,BRD-A41519720-001-02-2,ezetimibe,INN,SA58885,NA,MicroSource Discovery Systems Inc.,NA,1505203,OC(CC[C@@H]1[C@H](N(C1=O)c1ccc(F)cc1)c1ccc(O)cc1)c1ccc(F)cc1,NA,BRD-A41519720
famciclovir,LT00270,3324,famciclovir,1994,Less-DILI-Concern,3,Adverse reactions,.,Ambiguous DILI-concern,.,.,.,.,CC(=O)OCC(CCN1C=NC2=CN=C(N=C21)N)COC(=O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=50194d47-2761-4bfd-a35b-9c6a186694a5,2,BRD-K45033733-001-02-3,famciclovir,INN,SA59555,NA,MicroSource Discovery Systems Inc.,NA,1505201,CC(=O)OCC(CCn1cnc2cnc(N)nc12)COC(C)=O,NA,BRD-K45033733
felodipine,LT00397,3333,felodipine,1991,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,.,.,.,Postive,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dd39c559-5c5d-4d3b-9228-c44085e1699f,2,BRD-A30815329-001-03-0,felodipine,INN,SA83351,NA,Prestwick Chemical Inc.,NA,Prestw-478,CCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(Cl)c1Cl)C(=O)OC,NA,BRD-A30815329
fenofibrate,LT00098,3339,fenofibrate,1993,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,HH,Hepatotoxic,Positive,Postive,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2fe0bbd6-47a4-4836-beb1-0b635e3ab647,1,BRD-K50388907-001-04-9,fenofibrate,INN,SA59311,NA,MicroSource Discovery Systems Inc.,NA,1501010,CC(C)OC(=O)C(C)(C)Oc1ccc(cc1)C(=O)c1ccc(Cl)cc1,NA,BRD-K50388907
fenoldopam,LT00944,3341,fenoldopam,1997,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,.,.,.,.,C1CNCC(C2=CC(=C(C(=C21)Cl)O)O)C3=CC=C(C=C3)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=df4cd207-c3b8-4008-5290-02f296c2b4a6,2,BRD-A50684349-001-01-5,fenoldopam,INN,SA82630,NA,Biomol International Inc.,NA,AC-257,Oc1ccc(cc1)C1CNCCc2c(Cl)c(O)c(O)cc12,NA,BRD-A50684349
fexofenadine,LT01370,3348,fexofenadine,1996,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,NE,.,Negative,.,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6cf8da77-4272-4f88-9e5c-e83cfd80e9e9,2,BRD-A73368467-003-02-8,fexofenadine,INN,SA59801,NA,MicroSource Discovery Systems Inc.,NA,1504179,CC(C)(C(O)=O)c1ccc(cc1)C(O)CCCN1CCC(CC1)C(O)(c1ccccc1)c1ccccc1,NA,BRD-A73368467
finasteride,LT00167,57363,finasteride,1992,No-DILI-Concern,0,No match,Yes,vLess-DILI-Concern,.,non-hepatotixic,.,.,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=63ed2cec-c677-45bd-a802-64a9ec54046f,2,BRD-K01095011-001-03-5,finasteride,INN,SA83603,NA,Prestwick Chemical Inc.,NA,Prestw-717,CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C,NA,BRD-K01095011
flavoxate,LT00857,3354,flavoxate,1970,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,.,.,.,.,CC1=C(OC2=C(C1=O)C=CC=C2C(=O)OCCN3CCCCC3)C4=CC=CC=C4,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9422e67e-d64c-3ba1-b2b9-ca9d3eeda743,1,BRD-K47639036-003-03-3,flavoxate,INN,SA83428,NA,Prestwick Chemical Inc.,NA,Prestw-242,Cc1c(oc2c(cccc2c1=O)C(=O)OCCN1CCCCC1)-c1ccccc1,NA,BRD-K47639036
flecainide,LT01375,3356,flecainide,1985,Less-DILI-Concern,7,Adverse reactions,Yes,vLess-DILI-Concern,HH,.,Positive,Negative,C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4f6b78d4-8ac8-464b-bb78-ee70cbc97898,2,BRD-A09472452-001-02-8,flecainide,INN,SA82070,NA,Biomol International Inc.,NA,AC-130,FC(F)(F)COc1ccc(OCC(F)(F)F)c(c1)C(=O)NCC1CCCCN1,NA,BRD-A09472452
fluconazole,LT00179,3365,fluconazole,1990,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aa7572ca-0ea0-4259-bc79-acb88c9f492d,1,BRD-K05977355-001-02-6,fluconazole,INN,SA59792,NA,MicroSource Discovery Systems Inc.,NA,1503975,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,NA,BRD-K05977355
fulvestrant,LT00401,104741,fulvestrant,2002,Less-DILI-Concern,7,Adverse reactions,.,Ambiguous DILI-concern,.,.,.,.,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@@H](CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=83d7a440-e904-4e36-afb5-cb02b1c919f7,2,BRD-A90490067-001-01-9,BRD-A90490067,BROAD_CPD_ID,SA792300,NA,Tocris Bioscience,NA,1047,CC12CCC3C(C1CCC2O)C(CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)Cc1cc(O)ccc31,NA,BRD-A90490067
glimepiride,LT00173,3476,glimepiride,1995,Less-DILI-Concern,7,Adverse reactions,Yes,vLess-DILI-Concern,WE,.,Negative,.,CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=60e9397e-83b9-489e-9683-6f87e458bbaa,1,BRD-K42693031-001-01-8,glimepiride,common,SA792840,NA,Tocris Bioscience,NA,2396,CCC1=C(C)CN(C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC2CCC(C)CC2)C1=O,NA,BRD-K42693031
glipizide,LT00243,3478,glipizide,1984,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,.,.,.,.,CC1=NC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=06505b04-656c-47ef-83ba-ab977bdcaaf4,2,BRD-K12219985-001-04-8,glipizide,INN,SA82076,NA,Biomol International Inc.,NA,AC-120,Cc1cnc(cn1)C(=O)NCCc1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1,NA,BRD-K12219985
guanfacine,LT01422,3519,guanfacine,1986,Less-DILI-Concern,3,Adverse reactions,.,Ambiguous DILI-concern,.,.,.,.,C1=CC(=C(C(=C1)Cl)CC(=O)N=C(N)N)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9fc0bdc2-5ba2-48dd-aa87-7b0050a2d6ce,2,BRD-K32830106-003-11-3,guanfacine,INN,SA792286,NA,Tocris Bioscience,NA,1030,NC(=N)NC(=O)Cc1c(Cl)cccc1Cl,NA,BRD-K32830106
hydrocortisone,LT00188,5754,hydrocortisone,1951,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,.,.,Negative,.,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fb8f1024-e2d4-4394-ac45-d807a4caf4af,2,BRD-K93568044-001-03-1,hydrocortisone,INN,SA82968,NA,Prestwick Chemical Inc.,NA,Prestw-447,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO,NA,BRD-K93568044
isotretinoin,LT00234,5282379,isotretinoin,1982,Most-DILI-Concern,5,Warnings and precautions,Yes,vMost-DILI-Concern,HH,.,Positive,.,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C\C(=O)O)/C)/C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a31fd109-d0fd-4ab9-ba98-a3d64333c18d,1,BRD-K76723084-001-05-9,isotretinoin,INN,SA81917,NA,Biomol International Inc.,NA,GR102,CC(/C=C/C1=C(C)CCCC1(C)C)=C\C=C\C(C)=C/C(O)=O,NA,BRD-K76723084
isoxsuprine,LT02089,3783,isoxsuprine,.,No-DILI-concern,0,No match,.,vNo-DILI-Concern,NE,.,Negative,.,CC(COC1=CC=CC=C1)NC(C)C(C2=CC=C(C=C2)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e6582e24-9414-43b8-ac6f-b1422e3197cf,2,BRD-A74269027-003-03-8,isoxsuprine,INN,SA83102,NA,Prestwick Chemical Inc.,NA,Prestw-68,CC(COc1ccccc1)NC(C)C(O)c1ccc(O)cc1,NA,BRD-A74269027
ketoprofen,LT00023,3825,ketoprofen,1986,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,NE,.,Negative,.,CC(C1=CC=CC(=C1)C(=O)C2=CC=CC=C2)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c2c99853-1268-4998-a44b-2bf0c0b70fd2,2,BRD-A97739905-001-04-2,ketoprofen,INN,SA59359,NA,MicroSource Discovery Systems Inc.,NA,1501215,CC(C(O)=O)c1cccc(c1)C(=O)c1ccccc1,NA,BRD-A97739905
ketorolac,LT00204,3826,ketorolac,1989,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,HH,.,Positive,.,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=688f5dec-a6db-43c6-a1f8-5df99d08d395,1,BRD-A40639672-234-04-0,ketorolac tromethamine,USAN,SA59855,NA,MicroSource Discovery Systems Inc.,NA,1503925,OC(=O)C1CCn2c1ccc2C(=O)c1ccccc1,NA,BRD-A40639672
labetalol,LT00112,3869,labetalol,1984,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e10796ac-7a39-4985-b5d7-732d939b140f,1,BRD-A07440155-003-04-9,labetalol,INN,SA59461,NA,MicroSource Discovery Systems Inc.,NA,1503243,CC(CCc1ccccc1)NCC(O)c1ccc(O)c(c1)C(N)=O,NA,BRD-A07440155
leflunomide,LT00113,3899,leflunomide,1998,Most-DILI-Concern,8,Box warning,Yes,vMost-DILI-Concern,HH,.,Positive,Postive,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d3a4788f-6ff4-4804-9b41-7d6f0b27cd5c,1,BRD-K78692225-001-11-2,leflunomide,INN,SA792771,NA,Tocris Bioscience,NA,2228,Cc1oncc1C(=O)Nc1ccc(cc1)C(F)(F)F,NA,BRD-K78692225
lidocaine,LT01905,3676,lidocaine,1948,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,NE,.,Negative,.,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=165845cf-c59c-4dbe-af8f-ecb92a1fcdc6,2,BRD-K52662033-001-02-6,lidocaine,INN,SA82081,NA,Biomol International Inc.,NA,AC-128,CCN(CC)CC(=O)Nc1c(C)cccc1C,NA,BRD-K52662033
loperamide,LT02087,3955,loperamide,1976,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,NE,.,Negative,.,CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5c4a072e-88e6-4c35-adf2-fe81f3bcf4c9,2,BRD-K61250553-001-02-9,loperamide,INN,SA82082,NA,Biomol International Inc.,NA,AC-110,CN(C)C(=O)C(CCN1CCC(O)(CC1)c1ccc(Cl)cc1)(c1ccccc1)c1ccccc1,NA,BRD-K61250553
lovastatin,LT00576,53232,lovastatin,1987,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,.,non-hepatotixic,Negative,Postive,CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=058b94d0-9811-4dd2-a28d-377a26e5e6f8,1,BRD-K09416995-001-16-7,lovastatin,INN,SA792533,NA,Tocris Bioscience,NA,1530,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12,NA,BRD-K09416995
maprotiline,LT01503,4011,maprotiline,1980,Less-DILI-Concern,5,Adverse reactions,.,Ambiguous DILI-concern,WE,non-hepatotixic,Negative,.,CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c3ca69e6-1ea0-4c2c-abcb-7264b2e79a87,1,BRD-K25433859-003-11-4,maprotiline,INN,SA792235,NA,Tocris Bioscience,NA,935,CNCCCC12CCC(c3ccccc13)c1ccccc21,NA,BRD-K25433859
mebendazole,LT00308,4030,mebendazole,1974,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,HH,.,Positive,.,COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CC=C3,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c338415f-41e0-071d-8c51-a80a02ebf2cd,1,BRD-K77987382-001-05-8,mebendazole,primary-common,SA59319,NA,MicroSource Discovery Systems Inc.,NA,1501110,COC(=O)Nc1nc2ccc(cc2[nH]1)C(=O)c1ccccc1,NA,BRD-K77987382
meclizine,LT00792,4034,meclizine,1957,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,.,non-hepatotixic,.,.,CC1=CC(=CC=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4b10e789-3f47-4008-a989-40a419379a23,1,BRD-A50311610-300-04-7,meclozine,INN,SA58365,NA,MicroSource Discovery Systems Inc.,NA,1500376,Cc1cccc(CN2CCN(CC2)C(c2ccccc2)c2ccc(Cl)cc2)c1,NA,BRD-A50311610
meclizine,LT00792,4034,meclizine,1957,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,.,non-hepatotixic,.,.,CC1=CC(=CC=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4b10e789-3f47-4008-a989-40a419379a23,1,BRD-A50311610-003-13-8,meclozine,INN,SA1854924,NA,Prestwick Chemical Inc.,NA,Prestw-457,Cc1cccc(CN2CCN(CC2)C(c2ccccc2)c2ccc(Cl)cc2)c1,NA,BRD-A50311610
meloxicam,LT00117,54677470,meloxicam,2000,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,.,.,Negative,Postive,CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=06a401f0-4380-4081-86ed-a309a25abf6b,2,BRD-A84174393-001-02-0,meloxicam,INN,SA58529,NA,MicroSource Discovery Systems Inc.,NA,1504150,CN1C(C(=O)Nc2ncc(C)s2)C(=O)c2ccccc2S1(=O)=O,NA,BRD-A84174393
mesoridazine,LT01527,4078,mesoridazine,1970,Less-DILI-Concern,5,Adverse reactions,.,Ambiguous DILI-concern,HH,.,Positive,.,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)C,http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/16-774S073.pdf,2,BRD-A14395271-001-01-5,mesoridazine,INN,SA82601,NA,Biomol International Inc.,NA,NS-531,CN1CCCCC1CCN1c2ccccc2Sc2ccc(cc12)S(C)=O,NA,BRD-A14395271
metaxalone,LT00841,15459,metaxalone,1962,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,.,.,.,Negative,CC1=CC(=CC(=C1)OCC2CNC(=O)O2)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=edc1656d-26f0-95c2-ee8f-50518fd5affd,2,BRD-A94709349-001-02-6,metaxalone,INN,SA59546,NA,MicroSource Discovery Systems Inc.,NA,1504229,Cc1cc(C)cc(OCC2CNC(=O)O2)c1,NA,BRD-A94709349
methocarbamol,LT00581,4107,methocarbamol,1957,Less-DILI-Concern,5,Adverse reactions,.,Ambiguous DILI-concern,.,non-hepatotixic,.,.,COC1=CC=CC=C1OCC(COC(=O)N)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=32863f21-30ff-4a8b-a2e6-8ab14a37af0d,2,BRD-A31521121-001-04-1,methocarbamol,INN,SA58376,NA,MicroSource Discovery Systems Inc.,NA,1500397,COc1ccccc1OCC(O)COC(N)=O,NA,BRD-A31521121
methysergide,LT02072,9681,methysergide,1962,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,NE,.,Negative,.,CC[C@@H](CO)NC(=O)[C@H]1CN([C@@H]2CC3=CN(C4=CC=CC(=C34)C2=C1)C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3fae28ee-700e-4d4f-a040-02ef01a2aeb4,1,BRD-K35941380-001-01-7,methysergide,INN,SA82518,NA,Biomol International Inc.,NA,AC-577,CC[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2Cc3cn(C)c4cccc(C2=C1)c34,NA,BRD-K35941380
methysergide,LT02072,9681,methysergide,1962,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,NE,.,Negative,.,CC[C@@H](CO)NC(=O)[C@H]1CN([C@@H]2CC3=CN(C4=CC=CC(=C34)C2=C1)C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3fae28ee-700e-4d4f-a040-02ef01a2aeb4,1,BRD-A98725278-103-01-9,methysergide,to-be-curated,SA792311,NA,Tocris Bioscience,NA,1064,CCC(CO)NC(=O)C1CN(C)C2Cc3cn(C)c4cccc(C2=C1)c34,NA,BRD-A98725278
metoclopramide,LT01549,4168,metoclopramide,1979,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,HH,.,Positive,.,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2ad82e21-44b6-4a2f-a62f-05ca37347ea5,2,BRD-K75641298-001-01-5,metaclopramide,INN,SA82669,NA,Biomol International Inc.,NA,AC-840,CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC,NA,BRD-K75641298
metolazone,LT02046,4170,metolazone,1973,Less-DILI-Concern,3,Adverse reactions,.,Ambiguous DILI-concern,HH,.,Positive,.,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4813f476-3637-4f0f-abdd-c76c4074f8ae,2,BRD-A61793559-001-04-0,metolazone,INN,SA58801,NA,MicroSource Discovery Systems Inc.,NA,2300325,CC1Nc2cc(Cl)c(cc2C(=O)N1c1ccccc1C)S(N)(=O)=O,NA,BRD-A61793559
metoprolol,LT00309,4171,metoprolol,.,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,.,.,.,Postive,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bb05420c-fd24-4672-9f62-fdd313819287,1,BRD-A03623303-045-02-0,metoprolol tartrate,USAN,SA58385,NA,MicroSource Discovery Systems Inc.,NA,1500411,COCCc1ccc(OCC(O)CNC(C)C)cc1,NA,BRD-A03623303
mexiletine,LT01553,4178,mexiletine,1985,Most-DILI-Concern,3,Box warning,Yes,vMost-DILI-Concern,HH,.,Positive,.,CC1=C(C(=CC=C1)C)OCC(C)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=693da40b-26d4-40d6-87d1-158e256f40ab,1,BRD-A64092382-003-03-5,mexiletine,INN,SA58607,NA,MicroSource Discovery Systems Inc.,NA,1503929,CC(N)COc1c(C)cccc1C,NA,BRD-A64092382
midodrine,LT01558,4195,midodrine,1996,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,.,non-hepatotixic,.,.,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2b24f75c-539b-4a96-802e-f3cc3b55dae2,2,BRD-A79981887-003-04-0,midodrine,INN,SA59465,NA,MicroSource Discovery Systems Inc.,NA,1503257,COc1ccc(OC)c(c1)C(O)CNC(=O)CN,NA,BRD-A79981887
mifepristone,LT00184,55245,mifepristone,2000,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,.,.,.,.,CC#C[C@@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=542f3fae-8bc8-4f00-9228-e4b66c9ad6a9,2,BRD-K37270826-001-15-1,mifepristone,INN,SA1857173,NA,Sigma-Aldrich,NA,M8046,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)c1ccc(cc1)N(C)C,NA,BRD-K37270826
mifepristone,LT00184,55245,mifepristone,2000,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,.,.,.,.,CC#C[C@@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=542f3fae-8bc8-4f00-9228-e4b66c9ad6a9,2,BRD-K37270826-001-03-7,mifepristone,INN,SA63478,NA,EMD Biosciences,NA,475838,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)c1ccc(cc1)N(C)C,NA,BRD-K37270826
milrinone,LT00931,4197,milrinone,1987,Less-DILI-Concern,3,Adverse reactions,.,Ambiguous DILI-concern,.,.,.,.,CC1=C(C=C(C(=O)N1)C#N)C2=CC=NC=C2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ac43ba6b-635d-4129-8eea-96f3f5a4785e,2,BRD-K67080878-001-05-5,milrinone,INN,SA792517,NA,Tocris Bioscience,NA,1504,Cc1[nH]c(=O)c(cc1-c1ccncc1)C#N,NA,BRD-K67080878
minoxidil,LT00587,4201,minoxidil,1979,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,.,non-hepatotixic,.,.,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8f3800f0-b6da-4dfe-8c32-39bb5eb0262a,1,BRD-K14888893-001-02-3,minoxidil,INN,SA83120,NA,Prestwick Chemical Inc.,NA,Prestw-20,Nc1cc(nc(=N)n1O)N1CCCCC1,NA,BRD-K14888893
modafinil,LT00589,4236,modafinil,1998,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,.,non-hepatotixic,.,Postive,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f3b3097f-80b8-4410-af21-dcdea144e3c3,2,BRD-A16332958-001-02-4,modafinil,INN,SA58765,NA,MicroSource Discovery Systems Inc.,NA,1505361,NC(=O)CS(=O)C(c1ccccc1)c1ccccc1,NA,BRD-A16332958
nadolol,LT01582,39147,nadolol,1979,Less-DILI-Concern,3,Adverse reactions,.,Ambiguous DILI-concern,NE,.,Negative,Negative,CC(C)(C)NCC(COC1=CC=CC2=C1C[C@@H]([C@@H](C2)O)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d208918b-a356-4924-91d9-9593981fe0a6,2,BRD-A97454584-001-02-0,nadolol,INN,SA82812,NA,Prestwick Chemical Inc.,NA,Prestw-818,CC(C)(C)NCC(O)COc1cccc2CC(O)C(O)Cc12,NA,BRD-A97454584
nalbuphine,LT01586,5360630,nalbuphine,1979,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,.,non-hepatotixic,.,.,C1CC(C1)CN2CC[C@]34C5[C@H](CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=87d32eb5-6806-4aa4-8976-e3ba0fe871df,2,BRD-K66404838-003-03-8,nalbuphine,INN,SA83016,NA,Prestwick Chemical Inc.,NA,Prestw-118,O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC1CCC1)c45,NA,BRD-K66404838
naloxone,LT00592,5284596,naloxone,1971,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,.,.,.,.,C=CCN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b598c237-032d-4bb5-0e92-50eabd863dac,2,BRD-A41833852-001-01-9,naloxone,to-be-curated,SA792484,NA,Tocris Bioscience,NA,1419,Oc1ccc2CC3N(CC=C)CCC45C(Oc1c24)C(CCC35O)=NNC(=O)c1ccccc1,NA,BRD-A41833852
naloxone,LT00592,5284596,naloxone,1971,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,.,.,.,.,C=CCN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b598c237-032d-4bb5-0e92-50eabd863dac,2,BRD-K67511046-003-03-7,naloxone,INN,SA83423,NA,Prestwick Chemical Inc.,NA,Prestw-111,Oc1ccc2C[C@H]3N(CC=C)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O,NA,BRD-K67511046
naltrexone,LT00311,5360515,naltrexone,1984,Less-DILI-Concern,3,Warnings and precautions,.,Ambiguous DILI-concern,HH,.,Positive,.,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4a63f1e0-b2a3-4355-af61-852ea3521707,1,BRD-K88172511-310-03-8,naltrexone,INN,SA83017,NA,Prestwick Chemical Inc.,NA,Prestw-116,Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O,NA,BRD-K88172511
naltrexone,LT00311,5360515,naltrexone,1984,Less-DILI-Concern,3,Warnings and precautions,.,Ambiguous DILI-concern,HH,.,Positive,.,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4a63f1e0-b2a3-4355-af61-852ea3521707,1,BRD-A83855350-003-01-4,naltrexone,to-be-curated,SA792090,NA,Tocris Bioscience,NA,677,Oc1ccc2CC3N(CC4CC4)CCC45C(Oc1c24)C(=O)CCC35O,NA,BRD-A83855350
naproxen,LT00593,1302,naproxen,1976,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,WE,Hepatotoxic,Negative,Postive,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cb8a73cd-960c-4569-b2d6-abbcd2096689,1,BRD-A87719232-001-02-4,naproxen,INN,SA83018,NA,Prestwick Chemical Inc.,NA,Prestw-45,COc1ccc2cc(ccc2c1)C(C)C(O)=O,NA,BRD-A87719232
naproxen,LT00593,1302,naproxen,1976,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,WE,Hepatotoxic,Negative,Postive,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cb8a73cd-960c-4569-b2d6-abbcd2096689,1,BRD-K59197931-001-02-9,naproxen,INN,SA58394,NA,MicroSource Discovery Systems Inc.,NA,1500425,COc1ccc2cc(ccc2c1)[C@H](C)C(O)=O,NA,BRD-K59197931
nilutamide,LT01600,4493,nilutamide,1996,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,.,Hepatotoxic,.,.,CC1(C(=O)N(C(=O)N1)C2=CC(=C(C=C2)[N+](=O)[O-])C(F)(F)F)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6d2e5c32-3221-4605-955f-37c6bb61aef7,2,BRD-K23566484-001-04-5,nilutamide,INN,SA59513,NA,MicroSource Discovery Systems Inc.,NA,1504152,CC1(C)NC(=O)N(C1=O)c1ccc(c(c1)C(F)(F)F)[N+]([O-])=O,NA,BRD-K23566484
nimodipine,LT01601,4497,nimodipine,1988,Less-DILI-Concern,3,Adverse reactions,.,Ambiguous DILI-concern,HH,.,Positive,.,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d6a161d9-7e7a-4711-ba0e-c9040c42268d,2,BRD-A58048407-001-06-3,nimodipine,INN,SA82090,NA,Biomol International Inc.,NA,CA-211,COCCOC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC(C)C,NA,BRD-A58048407
nizatidine,LT00315,3033637,nizatidine,1988,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,.,.,.,.,CN/C(=C\[N+](=O)[O-])/NCCSCC1=CSC(=N1)CN(C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cbfb5d8a-a136-4d78-befa-d2cea6661030,1,BRD-K46652470-001-02-6,nizatidine,INN,SA82902,NA,Prestwick Chemical Inc.,NA,Prestw-921,CN\C(NCCSCc1csc(CN(C)C)n1)=C\[N+]([O-])=O,NA,BRD-K46652470
nortriptyline,LT01615,4543,nortriptyline,1964,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,.,Positive,.,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b58d473a-b19f-4d2a-b1ae-dd398d7a29e1,1,BRD-K91263825-001-02-8,nortriptyline,INN,SA58406,NA,MicroSource Discovery Systems Inc.,NA,1500442,CNCCC=C1c2ccccc2CCc2ccccc12,NA,BRD-K91263825
omeprazole,LT00206,4594,omeprazole,1989,Less-DILI-Concern,4,Adverse reactions,Yes,vLess-DILI-Concern,.,non-hepatotixic,.,Postive,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=276c3f70-890e-4afa-af48-8630f9689785,2,BRD-A55962179-001-01-5,omeprazole,primary-common,SA19145,NA,Maybridge,NA,KM 07219,COc1ccc2nc([nH]c2c1)S(=O)Cc1ncc(C)c(OC)c1C,NA,BRD-A55962179
orphenadrine,LT02085,4601,orphenadrine,1957,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,NE,non-hepatotixic,Negative,.,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8408d24e-3948-548d-bb12-b1edf0c05e12,2,BRD-A53576514-003-03-1,orphenadrine,INN,SA83233,NA,Prestwick Chemical Inc.,NA,Prestw-239,CN(C)CCOC(c1ccccc1)c1ccccc1C,NA,BRD-A53576514
oxaprozin,LT00429,4614,oxaprozin,1992,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,HH,.,Positive,Postive,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=765a0b09-d93b-eb04-7eed-1eb260500dc0,2,BRD-K25394294-001-04-0,oxaprozin,INN,SA58958,NA,MicroSource Discovery Systems Inc.,NA,1505267,OC(=O)CCc1nc(c(o1)-c1ccccc1)-c1ccccc1,NA,BRD-K25394294
paclitaxel,LT00430,36314,paclitaxel,1992,Less-DILI-Concern,4,Adverse reactions,Yes,vLess-DILI-Concern,HH,.,Positive,.,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ea28753a-8631-460a-bfdc-b101eb8ac84a,2,BRD-A23723433-001-01-2,taxol,to-be-curated,SA792331,NA,Tocris Bioscience,NA,1097,CC(=O)OC1C2=C(C)C(CC(O)(C(OC(=O)c3ccccc3)C3C4(COC4CC(O)C3(C)C1=O)OC(C)=O)C2(C)C)OC(=O)C(O)C(NC(=O)c1ccccc1)c1ccccc1,NA,BRD-A23723433
pantoprazole,LT00606,4679,pantoprazole,2000,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,.,.,.,.,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=742ca9f4-9fba-44d4-29a8-1fe3a04f1af6,2,BRD-A22380646-001-01-5,pantoprazole,INN,SA58780,NA,MicroSource Discovery Systems Inc.,NA,1505818,COc1ccnc(CS(=O)c2nc3cc(OC(F)F)ccc3[nH]2)c1OC,NA,BRD-A22380646
papaverine,LT01637,4680,papaverine,.,Most-DILI-Concern,5,Warnings and precautions,Yes,vMost-DILI-Concern,.,.,.,.,COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9e5e2ce4-7a57-4c61-a826-64c8d11d038e,2,BRD-K15567136-001-01-1,papaverine hydrochloride,USAN,SA38815,NA,AnalytiCon Discovery GmbH,NA,NP-014100,COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC,NA,BRD-K15567136
paroxetine,LT00128,43815,paroxetine,1992,Less-DILI-Concern,8,Adverse reactions,Yes,vLess-DILI-Concern,WE,non-hepatotixic,Negative,Postive,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7b9e9d36-9b7d-4d47-8d8a-d37da85e7b24,1,BRD-K37991163-050-05-1,paroxetine,INN,SA792733,NA,Tocris Bioscience,NA,2141,Fc1ccc(cc1)[C@@H]1CCNC[C@H]1COc1ccc2OCOc2c1,NA,BRD-K37991163
pentoxifylline,LT01652,4740,pentoxifylline,1984,Less-DILI-Concern,5,Adverse reactions,.,Ambiguous DILI-concern,.,.,.,.,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ff347283-b9ce-4570-8501-43cab7e2ecc8,2,BRD-K57569181-001-04-4,pentoxifylline,INN,SA59700,NA,MicroSource Discovery Systems Inc.,NA,1503611,CC(=O)CCCCn1c(=O)n(C)c2ncn(C)c2c1=O,NA,BRD-K57569181
perindopril,LT00955,107807,perindopril,1993,Less-DILI-Concern,3,Adverse reactions,.,Ambiguous DILI-concern,.,.,.,Negative,CCC[C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cbc5b3c3-4d2c-4fa0-adbb-8ddf42e881c5,2,BRD-K92731339-227-02-3,perindopril,INN,SA59563,NA,MicroSource Discovery Systems Inc.,NA,1505212,CCC[C@H](N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(O)=O)C(=O)OCC,NA,BRD-K92731339
perphenazine,LT01655,4748,perphenazine,1957,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,.,.,.,.,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0958af4c-87ef-41fd-90a1-ec3e57146945,2,BRD-K10995081-001-05-5,perphenazine,INN,SA83132,NA,Prestwick Chemical Inc.,NA,Prestw-125,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc23)CC1,NA,BRD-K10995081
phentolamine,LT00433,5775,phentolamine,1952,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,HH,.,Positive,.,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=658672ce-5251-4d17-9a5f-58d3abf62ed1,1,BRD-K90333595-001-02-8,phentolamine,INN,SA82099,NA,Biomol International Inc.,NA,AC-121,Cc1ccc(cc1)N(CC1=NCCN1)c1cccc(O)c1,NA,BRD-K90333595
pimozide,LT01672,16362,pimozide,1984,No-DILI-concern,0,No match,.,vNo-DILI-Concern,NE,.,Negative,.,C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fd9729c3-545f-4d34-9bc7-72b61e028fc4,2,BRD-K01292756-001-06-0,pimozide,INN,SA82101,NA,Biomol International Inc.,NA,AC-109,Fc1ccc(cc1)C(CCCN1CCC(CC1)n1c2ccccc2[nH]c1=O)c1ccc(F)cc1,NA,BRD-K01292756
pindolol,LT01673,4828,pindolol,1982,No-DILI-concern,0,No match,.,vNo-DILI-Concern,NE,.,Negative,.,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=05dfb38c-b832-4ae0-b28b-d271008e670b,2,BRD-A97701745-001-04-6,pindolol,INN,SA58427,NA,MicroSource Discovery Systems Inc.,NA,1500488,CC(C)NCC(O)COc1cccc2[nH]ccc12,NA,BRD-A97701745
piroxicam,LT01679,5280452,piroxicam,1982,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,HH,Hepatotoxic,Positive,.,CN1/C(=C(\NC2=CC=CC=N2)/O)/C(=O)C3=CC=CC=C3S1(=O)=O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3fa3d666-3154-23a7-1c69-915cd6f6a87c,1,BRD-A57382968-001-06-8,piroxicam,INN,SA82316,NA,Biomol International Inc.,NA,EI219,CN1C(C(=O)Nc2ccccn2)C(=O)c2ccccc2S1(=O)=O,NA,BRD-A57382968
pravastatin,LT00186,54687,pravastatin,1991,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,.,non-hepatotixic,.,Postive,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=99e0e848-f8f3-4b42-b880-8fbc42633948,1,BRD-A71816415-236-02-7,pravastatin,INN,SA58775,NA,MicroSource Discovery Systems Inc.,NA,1505803,CCC(C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)C12,NA,BRD-A71816415
pravastatin,LT00186,54687,pravastatin,1991,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,.,non-hepatotixic,.,Postive,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=99e0e848-f8f3-4b42-b880-8fbc42633948,1,BRD-K60511616-236-01-4,pravastatin,primary-common,SA792815,NA,Tocris Bioscience,NA,2318,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12,NA,BRD-K60511616
praziquantel,LT00225,4891,praziquantel,1982,Less-DILI-Concern,3,Warnings and precautions,.,Ambiguous DILI-concern,NE,.,Negative,.,C1CCC(CC1)C(=O)N2CC3C4=CC=CC=C4CCN3C(=O)C2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=34ce1cdd-648e-4f1e-8512-bf3d4cc22eb9,2,BRD-A21858158-001-04-5,praziquantel,INN,SA58430,NA,MicroSource Discovery Systems Inc.,NA,1500494,O=C(C1CCCCC1)N1CC2N(CCc3ccccc23)C(=O)C1,NA,BRD-A21858158
prazosin,LT00435,4893,prazosin,1976,Less-DILI-Concern,3,Adverse reactions,.,Ambiguous DILI-concern,.,.,.,.,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7293cef3-ef9e-40dc-9995-875ef047f693,2,BRD-K49111258-001-02-8,prazosin,INN,SA82319,NA,Biomol International Inc.,NA,AC-146,COc1cc2nc(nc(N)c2cc1OC)N1CCN(CC1)C(=O)c1ccco1,NA,BRD-K49111258
prednisone,LT00180,5865,prednisone,1955,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,WE,non-hepatotixic,Negative,.,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9b682e76-7b10-43a9-9527-81a633b7d0c0,2,BRD-A62525898-001-02-9,prednisone,INN,SA58636,NA,MicroSource Discovery Systems Inc.,NA,1500499,C[C@]12CC(=O)C3C(CCC4=CC(=O)C=C[C@]34C)C1CC[C@]2(O)C(=O)CO,NA,BRD-A62525898
primaquine,LT00613,4908,primaquine,1952,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,WE,.,Negative,.,CC(CCCN)NC1=C2C(=CC(=C1)OC)C=CC=N2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1bfbf4ae-81b8-4160-a00d-6322aadd4b59,1,BRD-A55913614-316-04-7,primaquine,INN,SA58432,NA,MicroSource Discovery Systems Inc.,NA,1500500,COc1cc(NC(C)CCCN)c2ncccc2c1,NA,BRD-A55913614
primidone,LT00261,4909,primidone,1954,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,NE,.,Negative,.,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=418a70aa-8480-4748-a1a8-af39f4962bf0,1,BRD-K32247306-001-04-7,primidone,INN,SA58433,NA,MicroSource Discovery Systems Inc.,NA,1500501,CCC1(C(=O)NCNC1=O)c1ccccc1,NA,BRD-K32247306
probenecid,LT01698,4911,probenecid,1951,Less-DILI-Concern,6,Adverse reactions,.,Ambiguous DILI-concern,WE,.,Negative,Negative,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9eeedc83-f6cc-4383-83ec-d7992a96b7b4,2,BRD-K95237249-001-04-2,probenecid,INN,SA58434,NA,MicroSource Discovery Systems Inc.,NA,1500502,CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(O)=O,NA,BRD-K95237249
procainamide,LT01699,4913,procainamide,1950,Less-DILI-Concern,4,Adverse reactions,Yes,vLess-DILI-Concern,.,.,.,.,CCN(CC)CCNC(=O)C1=CC=C(C=C1)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=17e47845-daad-434c-a784-6d3875b0d704,2,BRD-K75089421-001-02-5,procainamide,INN,SA82103,NA,Biomol International Inc.,NA,AC-127,CCN(CC)CCNC(=O)c1ccc(N)cc1,NA,BRD-K75089421
prochlorperazine,LT00437,4917,prochlorperazine,1956,Less-DILI-Concern,2,Adverse reactions,Yes,vLess-DILI-Concern,HH,Hepatotoxic,Positive,.,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6b0e958b-fde0-74ea-b196-1e62f90b5bbe,2,BRD-K19352500-332-03-7,prochlorperazine,INN,SA83050,NA,Prestwick Chemical Inc.,NA,Prestw-399,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc23)CC1,NA,BRD-K19352500
propafenone,LT01705,4932,propafenone,1989,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,NE,.,Negative,Postive,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e4412a6a-ed4d-410d-8abb-86e1d7b72a3c,2,BRD-A26334849-001-02-1,propafenone,INN,SA82104,NA,Biomol International Inc.,NA,AC-124,CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1,NA,BRD-A26334849
propofol,LT01708,4943,propofol,1989,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,NE,.,Negative,Postive,CC(C)C1=C(C(=CC=C1)C(C)C)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b6d54dc1-b73d-43de-ab9e-6c5ae420f683,2,BRD-K82255054-001-04-3,propofol,INN,SA83783,NA,Prestwick Chemical Inc.,NA,Prestw-931,CC(C)c1cccc(C(C)C)c1O,NA,BRD-K82255054
protriptyline,LT00848,4976,protriptyline,1967,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,.,.,.,.,CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a6be6521-7179-442f-8c45-69711a2c3290,2,BRD-K42098891-003-03-1,protriptyline,INN,SA83673,NA,Prestwick Chemical Inc.,NA,Prestw-930,CNCCCC1c2ccccc2C=Cc2ccccc12,NA,BRD-K42098891
pyrimethamine,LT01716,4993,pyrimethamine,1953,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,HH,.,Positive,Postive,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3e4d5027-7939-480f-ae19-82e764d9fa97 ,2,BRD-K88429204-001-04-7,pyrimethamine,INN,SA59581,NA,MicroSource Discovery Systems Inc.,NA,1500520,CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1,NA,BRD-K88429204
quinidine,LT01725,441074,quinidine,1950,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,HH,Hepatotoxic,Positive,.,COC1=CC2=C(C=CN=C2C=C1)[C@@H]([C@H]3C[C@@H]4CCN3C[C@@H]4C=C)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a90a03b0-ffbe-4cf6-90b5-bfb0412a1cb2,2,BRD-K70799801-311-02-7,quinidine gluconate,USP,SA83173,NA,Prestwick Chemical Inc.,NA,Prestw-280,COc1ccc2nccc([C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C)c2c1,NA,BRD-K70799801
raloxifene,LT00183,5035,raloxifene,1997,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,WE,non-hepatotixic,Negative,.,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cbee500a-34e2-4819-987b-da107eacbb27,2,BRD-K63828191-003-07-3,raloxifene,INN,SA792790,NA,Tocris Bioscience,NA,2280,Oc1ccc(cc1)-c1sc2cc(O)ccc2c1C(=O)c1ccc(OCCN2CCCCC2)cc1,NA,BRD-K63828191
risperidone,LT01735,5073,risperidone,1993,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,HH,.,Positive,.,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a0a21bec-68f0-444e-a611-d0602859410c,2,BRD-K53857191-001-04-5,risperidone,INN,SA82616,NA,Biomol International Inc.,NA,AC-758,Cc1nc2CCCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12,NA,BRD-K53857191
ropinirole,LT00990,5095,ropinirole,1997,Less-DILI-Concern,4,Adverse reactions,Yes,vLess-DILI-Concern,.,.,.,.,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ec0612a1-ccb1-bb51-8881-04faf491e093,2,BRD-K15933101-003-01-2,ropinirole,USAN,SA82649,NA,Biomol International Inc.,NA,D-113,CCCN(CCC)CCc1cccc2NC(=O)Cc12,NA,BRD-K15933101
saquinavir,LT01746,60787,saquinavir,1995,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,HH,.,Positive,.,CC(C)(C)NC(=O)[C@@H]1CC2CCCCC2CN1C[C@H]([C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c00d1607-ac36-457b-a34b-75ad74f9cf0a,1,BRD-K09963420-066-03-4,saquinavir,INN,SA83794,NA,Prestwick Chemical Inc.,NA,Prestw-1114,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1,NA,BRD-K09963420
scopolamine,LT01974,5184,scopolamine,1979,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,.,.,.,.,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b85b3ca0-89ce-44fe-b748-62e160e8c349,2,BRD-K89923877-003-02-4,scopolamine,primary-common,SA83551,NA,Prestwick Chemical Inc.,NA,Prestw-877,CN1[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)c1ccccc1,NA,BRD-K89923877
scopolamine,LT01974,5184,scopolamine,1979,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,.,.,.,.,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b85b3ca0-89ce-44fe-b748-62e160e8c349,2,BRD-A14566392-004-03-5,scopolamine,to-be-curated,SA792479,NA,Tocris Bioscience,NA,1414,CN1C2CC(CC1C1OC21)OC(=O)C(CO)c1ccccc1,NA,BRD-A14566392
sildenafil,LT01033,5212,sildenafil,1998,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,.,.,.,.,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=39a5247d-f173-499d-9e4d-d17cf3dff63e,2,BRD-K79759585-001-02-1,sildenafil,INN,SA59772,NA,MicroSource Discovery Systems Inc.,NA,1504099,CCCc1nn(C)c2c1nc([nH]c2=O)-c1cc(ccc1OCC)S(=O)(=O)N1CCN(C)CC1,NA,BRD-K79759585
simvastatin,LT00142,54454,simvastatin,1991,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,.,non-hepatotixic,Negative,Postive,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9999f4dc-60be-4c8f-8063-78144ed4431f,1,BRD-K22134346-001-04-1,simvastatin,INN,SA58549,NA,MicroSource Discovery Systems Inc.,NA,1504236,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12,NA,BRD-K22134346
sirolimus,LT00443,6436030,sirolimus,1999,Less-DILI-Concern,8,Adverse reactions,Yes,vLess-DILI-Concern,.,.,.,.,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)CC4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3275b824-3f82-4151-2ab2-0036a9ba0acc,2,BRD-K89626439-001-01-0,BRD-K89626439,BROAD_CPD_ID,SA1901306,NA,University of New Mexico MLSC,NA,5284616,CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C/C=C/C=C(C)/[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1O,NA,BRD-K89626439
tamoxifen,LT00152,2733526,tamoxifen,1977,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8e4710a7-8757-49be-8bec-a1dc39e6c695,1,BRD-K43744935-048-01-6,tamoxifen,to-be-curated,SA792269,NA,Tocris Bioscience,NA,999,CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,NA,BRD-K43744935
tamoxifen,LT00152,2733526,tamoxifen,1977,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8e4710a7-8757-49be-8bec-a1dc39e6c695,1,BRD-K93754473-001-02-9,tamoxifen,INN,SA82346,NA,Biomol International Inc.,NA,S-650,CC\C(c1ccccc1)=C(/c1ccccc1)c1ccc(OCCN(C)C)cc1,NA,BRD-K93754473
testosterone,LT00223,6013,testosterone,1953,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,.,non-hepatotixic,.,Postive,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9af8ef50-f650-44ca-a272-135bfce9daca,2,BRD-A55393291-001-02-4,testosterone,INN,SA58667,NA,MicroSource Discovery Systems Inc.,NA,307023,C[C@]12CCC3C(CCC4=CC(=O)CC[C@]34C)C1CC[C@@H]2O,NA,BRD-A55393291
testosterone,LT00223,6013,testosterone,1953,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,.,non-hepatotixic,.,Postive,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9af8ef50-f650-44ca-a272-135bfce9daca,2,BRD-K90553655-001-03-6,testosterone propionate,USAN,SA83062,NA,Prestwick Chemical Inc.,NA,Prestw-401,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,NA,BRD-K90553655
thalidomide,LT00450,5426,thalidomide,1998,Less-DILI-Concern,4,Adverse reactions,Yes,vLess-DILI-Concern,.,.,.,.,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2eda833b-1357-4ed4-a093-194524fcb061,2,BRD-A93255169-001-06-9,thalidomide,INN,SA82349,NA,Biomol International Inc.,NA,T-115,O=C1N(C2CCC(=O)NC2=O)C(=O)c2ccccc12,NA,BRD-A93255169
thiotepa,LT01804,5453,thiotepa,1959,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,.,.,.,.,C1CN1P(=S)(N2CC2)N3CC3,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=89a11272-62a6-45d6-9ace-ea55de178dc3,2,BRD-K09631521-001-02-4,thiotepa,INN,SA59474,NA,MicroSource Discovery Systems Inc.,NA,1503324,S=P(N1CC1)(N1CC1)N1CC1,NA,BRD-K09631521
ticlopidine,LT00227,5472,ticlopidine,1991,Most-DILI-Concern,4,Warnings and precautions,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b1ebcf65-f6c3-4267-99aa-1c6b203dffc7,1,BRD-K00603606-003-03-4,ticlopidine,INN,SA83104,NA,Prestwick Chemical Inc.,NA,Prestw-47,Clc1ccccc1CN1CCc2sccc2C1,NA,BRD-K00603606
timolol,LT01815,33624,timolol,1978,Less-DILI-Concern,5,Adverse reactions,.,Ambiguous DILI-concern,HH,.,Positive,Negative,CC(C)(C)NC[C@@H](COC1=NSN=C1N2CCOCC2)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=57c62928-63d8-4505-9b9e-c085a3a12c95,2,BRD-K08806317-050-03-6,timolol,INN,SA83678,NA,Prestwick Chemical Inc.,NA,Prestw-948,CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1,NA,BRD-K08806317
tolazamide,LT00266,5503,tolazamide,1966,Less-DILI-Concern,2,Adverse reactions,Yes,vLess-DILI-Concern,HH,.,Positive,.,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CCCCCC2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c8e26b95-96f4-4b0d-929d-31dd240cfe44,2,BRD-K32164935-001-06-8,tolazamide,INN,SA82114,NA,Biomol International Inc.,NA,KC-135,Cc1ccc(cc1)S(=O)(=O)NC(=O)NN1CCCCCC1,NA,BRD-K32164935
tolbutamide,LT00453,5505,tolbutamide,1961,Less-DILI-Concern,2,Adverse reactions,.,Ambiguous DILI-concern,HH,.,Positive,.,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3995eed8-39ec-ce5e-8cc2-062f93445c8d,1,BRD-K85119730-001-06-5,tolbutamide,INN,SA82115,NA,Biomol International Inc.,NA,AC-117,CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1,NA,BRD-K85119730
tolmetin,LT01820,5509,tolmetin,1976,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,HH,.,Positive,.,CC1=CC=C(C=C1)C(=O)C2=CC=C(N2C)CC(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=332731f4-6625-4b6c-9d8f-36e8a11d2d0d,2,BRD-K82562631-236-02-0,tolmetin,INN,SA58483,NA,MicroSource Discovery Systems Inc.,NA,1500582,Cc1ccc(cc1)C(=O)c1ccc(CC(O)=O)n1C,NA,BRD-K82562631
triamterene,LT01833,5546,triamterene,1964,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,.,.,.,.,C1=CC=C(C=C1)C2=NC3=C(N=C2N)N=C(N=C3N)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5012f997-9fb2-4c3d-99fd-4f7efd7c39af,2,BRD-K92049597-001-04-2,triamterene,INN,SA59252,NA,MicroSource Discovery Systems Inc.,NA,1500589,Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1,NA,BRD-K92049597
trimethobenzamide,LT01841,5577,trimethobenzamide,1974,Less-DILI-Concern,5,Adverse reactions,.,Ambiguous DILI-concern,HH,.,Positive,.,CN(C)CCOC1=CC=C(C=C1)CNC(=O)C2=CC(=C(C(=C2)OC)OC)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=34cd4cf0-5990-48b3-10ec-206e2e33f7fe,2,BRD-K34415467-003-04-9,trimethobenzamide,INN,SA59257,NA,MicroSource Discovery Systems Inc.,NA,1500594,COc1cc(cc(OC)c1OC)C(=O)NCc1ccc(OCCN(C)C)cc1,NA,BRD-K34415467
valsartan,LT01857,60846,valsartan,1996,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,WE,non-hepatotixic,Negative,Postive,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5ddba454-f3e6-43c2-a7a6-58365d297213,2,BRD-K45158365-001-02-3,valsartan,INN,SA59711,NA,MicroSource Discovery Systems Inc.,NA,1505209,CCCCC(=O)N(Cc1ccc(cc1)-c1ccccc1-c1nn[nH]n1)[C@@H](C(C)C)C(O)=O,NA,BRD-K45158365
venlafaxine,LT00174,5656,venlafaxine,1993,Less-DILI-Concern,7,Adverse reactions,Yes,vLess-DILI-Concern,.,non-hepatotixic,.,Postive,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e5a31f69-c237-49b7-83a2-d04eebbc30ce,1,BRD-A51714012-001-02-3,venlafaxine,INN,SA58869,NA,MicroSource Discovery Systems Inc.,NA,1504171,COc1ccc(cc1)C(CN(C)C)C1(O)CCCCC1,NA,BRD-A51714012
verapamil,LT00332,2520,verapamil,1981,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,WE,.,Negative,Postive,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a0343397-897b-46d6-943f-a87e07e1de10,1,BRD-A09533288-001-02-7,verapamil,INN,SA82118,NA,Biomol International Inc.,NA,CA-215,COc1ccc(CCN(C)CCCC(C#N)(C(C)C)c2ccc(OC)c(OC)c2)cc1OC,NA,BRD-A09533288
vinblastine,LT00177,13342,vinblastine,1965,No-DILI-Concern,0,No match,.,vNo-DILI-Concern,NE,.,Negative,.,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f073b58e-56d6-4c8d-a2ce-b37719402d77,2,BRD-A22783572-065-01-3,vinblastine sulfate,common,SA792405,NA,Tocris Bioscience,NA,1256,CCC1(O)CC2CN(C1)CCc1c([nH]c3ccccc13)C(C2)(C(=O)OC)c1cc2c(cc1OC)N(C)C1C22CCN3CC=CC(CC)(C23)C(C(=O)OC)C1(O)C(=O)OC,NA,BRD-A22783572
warfarin,LT00647,6691,warfarin,1954,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,WE,non-hepatotixic,Negative,.,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3fb2aa58-3a40-4255-a261-e2db5b9a5dde,1,BRD-A24514565-236-01-6,warfarin,INN,SA39424,NA,ChemBridge Corporation,NA,5103026,CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O,NA,BRD-A24514565
